CCM
PRAH

CrestPoint Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

CrestPoint Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$364K Buy
4,000
+400
+11% +$33.3K 0.2% 144
2017
Q3 		$274K Buy
+3,600
New +$272K 0.12% 198

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CrestPoint Capital Management's PRAH Position: Q4 2017 in Review

CrestPoint Capital Management increased its PRA Health Sciences, Inc. (PRAH) stake by 11% in Q4 2017, buying an estimated $33.3K and bringing the position to 4,000 shares worth $364K. The position accounts for 0.2% of the portfolio, ranked #144.

CrestPoint Capital Management first reported a position in PRAH in Q3 2017 and has held it in 2 quarters since. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

  • CrestPoint Capital Management held 4,000 shares of PRA Health Sciences, Inc. worth $364K as of Q4 2017.
  • CrestPoint Capital Management bought 400 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $33.3K.
  • PRA Health Sciences, Inc. made up 0.2% of CrestPoint Capital Management's portfolio in Q4 2017, its #144 holding.
  • CrestPoint Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2017 and has held it in 2 quarters since.
  • 282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.